High-dose rate endorectal brachytherapy for rectal cancer: A state-of-the-art review.
Cheng T, Peng R, Qu A, Wang H.
Cancer Sci. 2023 Nov;114(11):4145-4156. doi: 10.1111/cas.15959. Epub 2023 Sep 13.
Modern development of high-dose-rate brachytherapy.
Itami J.
Jpn J Clin Oncol. 2020 May 5;50(5):490-501. doi: 10.1093/jjco/hyaa029.
Ultra-high dose rate FLASH radiation therapy for cancer.
Kim MM, Zou W.
Med Phys. 2023 Jun;50 Suppl 1(Suppl 1):58-61. doi: 10.1002/mp.16271. Epub 2023 Feb 21.
High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome.
Strouthos I, Karagiannis E, Zamboglou N, Ferentinos K.
Cancer Rep (Hoboken). 2022 Jan;5(1):e1450. doi: 10.1002/cnr2.1450. Epub 2021 Jun 23.
High dose-rate brachytherapy in the treatment of prostate cancer.
Mendez LC, Morton GC.
Transl Androl Urol. 2018 Jun;7(3):357-370. doi: 10.21037/tau.2017.12.08.
High Dose Rate Brachytherapy in High-Risk Localised Disease - Why Do Anything Else?
Morton GC, Alrashidi SM.
Clin Oncol (R Coll Radiol). 2020 Mar;32(3):163-169. doi: 10.1016/j.clon.2019.11.003. Epub 2019 Nov 30.
High-dose-rate brachytherapy as monotherapy for prostate cancer.
Demanes DJ, Ghilezan MI.
Brachytherapy. 2014 Nov-Dec;13(6):529-41. doi: 10.1016/j.brachy.2014.03.002. Epub 2014 Jul 30.
High-dose-rate brachytherapy boost for prostate cancer: rationale and technique.
Morton GC.
J Contemp Brachytherapy. 2014 Oct;6(3):323-30. doi: 10.5114/jcb.2014.45759. Epub 2014 Oct 6.
High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status.
Tselis N, Hoskin P, Baltas D, Strnad V, Zamboglou N, Rödel C, Chatzikonstantinou G.
Clin Oncol (R Coll Radiol). 2017 Jul;29(7):401-411. doi: 10.1016/j.clon.2017.02.015. Epub 2017 Mar 22.
Ultra-high dose rate FLASH irradiator at the radiological research accelerator facility.
Garty G, Obaid R, Deoli N, Royba E, Tan Y, Harken AD, Brenner DJ.
Sci Rep. 2022 Dec 22;12(1):22149. doi: 10.1038/s41598-022-19211-7.
